UM

Browse/Search Results:  1-10 of 19 Help

Selected(0)Clear Items/Page:    Sort:
Standard: Human intestinal cancer organoids Other
2023-12-01
Authors:  Hanqing Lin1;  Yalong Wang;  Chunyan Cheng;  Yuxin Qian;  Jie Hao; et al.
Favorite | TC[WOS]:1 TC[Scopus]:1 | Submit date:2023/08/03
Anti-breast cancer-induced cardiomyopathy: Mechanisms and future directions Journal article
Liu, Chunping, Chen, Huiqi, Guo, Sien, Liu, Qiaojing, Chen, Zhijun, Huang, Haiding, Zhao, Qi, Li, Longmei, Cen, Huan, Jiang, Zebo, Luo, Qiyuan, Chen, Xiaoling, Zhao, Jiaxiong, Chen, Wensheng, Yang, Phillip C., Wang, Lei. Anti-breast cancer-induced cardiomyopathy: Mechanisms and future directions[J]. Biomedicine and Pharmacotherapy, 2023, 166.
Authors:  Liu, Chunping;  Chen, Huiqi;  Guo, Sien;  Liu, Qiaojing;  Chen, Zhijun; et al.
Favorite | TC[WOS]:7 TC[Scopus]:9  IF:6.9/6.8 | Submit date:2024/01/10
Anthracycline  Breast cancer  Cardiomyopathy  Cardiotoxicity  Chemotherapy  Trastuzumab  
Anti-breast cancer-induced cardiomyopathy: Mechanisms and future directions Review article
2023
Authors:  Chunping Liu;  Huiqi Chen;  Sien Guo;  Qiaojing Liu;  Zhijun Chen; et al.
Favorite | TC[WOS]:7 TC[Scopus]:9  IF:6.9/6.8 | Submit date:2023/09/22
Anthracycline  Breast Cancer  Cardiomyopathy  Cardiotoxicity  Chemotherapy  Trastuzumab  
Development of glycyrrhetinic acid ligand-functionalized liposomes for targeting hepatocellular carcinoma: Synthesis, preparation, characterization, and evaluation Journal article
Yuan Lin, Yimin Zhang, Zhuang Xiong, Min Wu, Muling Zeng, Chuangnan Li, Fujin Liu, Yazhi Liao, Chunping Liu, Jing Chen. Development of glycyrrhetinic acid ligand-functionalized liposomes for targeting hepatocellular carcinoma: Synthesis, preparation, characterization, and evaluation[J]. Arabian Journal of Chemistry, 2023, 16(10), 105131.
Authors:  Yuan Lin;  Yimin Zhang;  Zhuang Xiong;  Min Wu;  Muling Zeng; et al.
Favorite | TC[WOS]:2 TC[Scopus]:2  IF:5.3/5.6 | Submit date:2023/08/03
Ga-da-ch  Hepatocellular-targeting  Ligand Synthesis  Liposomal Preparation  Physicochemical Characterization  
Standard: Human intestinal organoids Other
2023-06-14
Authors:  Yalong Wang;  Hanqing Lin;  Lianzheng Zhao;  Fan Hong;  Jie Hao; et al.
Favorite | TC[WOS]:3 TC[Scopus]:5 | Submit date:2023/08/03
Bisabolane-Type Sesquiterpenoids with a Tetrahydrofuran or Tetrahydropyran Ring from Vernonia solanifolia Journal article
Li,Zeng, Yang,Yue, Chen,Cheng, Lin,Ligen, Tang,Chunping, Ye,Yang. Bisabolane-Type Sesquiterpenoids with a Tetrahydrofuran or Tetrahydropyran Ring from Vernonia solanifolia[J]. Journal of Natural Products, 2023, 86(6), 1550-1563.
Authors:  Li,Zeng;  Yang,Yue;  Chen,Cheng;  Lin,Ligen;  Tang,Chunping; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:3.3/3.9 | Submit date:2023/08/03
Immunity: Psoriasis comorbid with atherosclerosis Other
2022-12-15
Authors:  Chunping Liu;  Huiqi Chen;  Yanjiao Liu;  Haiding Huang;  Wanling Yu; et al.
Favorite | TC[WOS]:8 TC[Scopus]:8 | Submit date:2023/01/30
Atherosclerosis  Comorbidity  Immunology  Inflammation  Psoriasis  
PCSK9 Inhibition: From Current Advances to Evolving Future Review article
2022
Authors:  Liu, Chunping;  Chen, Jing;  Chen, Huiqi;  Zhang, Tong;  He, Dongyue; et al.
Favorite | TC[WOS]:40 TC[Scopus]:46  IF:5.1/6.0 | Submit date:2022/11/07
Cardiovascular Disease  Pcsk9 Inhibitors  Clinical Applications  Security  Research Status  
Extracellular vesicles in pancreatic cancer immune escape: Emerging roles and mechanisms Review article
2022
Authors:  Liu, Chunping;  He, Dongyue;  Li, Longmei;  Zhang, Shihui;  Wang, Lei; et al.
Favorite | TC[WOS]:26 TC[Scopus]:28  IF:9.1/9.0 | Submit date:2022/08/24
Pancreatic Cancer  Extracellular Vesicles  Immune Escape  Tumor Immune  Microenvironment  Exosomes  Cancer Immunotherapy  
Engineered extracellular vesicles and their mimetics for cancer immunotherapy Journal article
Liu, Chunping, Wang, Yichao, Li, Longmei, He, Dongyue, Chi, Jiaxin, Li, Qin, Wu, Yixiao, Zhao, Yunxuan, Zhang, Shihui, Wang, Lei, Fan, Zhijin, Liao, Yuhui. Engineered extracellular vesicles and their mimetics for cancer immunotherapy[J]. JOURNAL OF CONTROLLED RELEASE, 2022, 349, 679-698.
Authors:  Liu, Chunping;  Wang, Yichao;  Li, Longmei;  He, Dongyue;  Chi, Jiaxin; et al.
Favorite | TC[WOS]:80 TC[Scopus]:86  IF:10.5/10.6 | Submit date:2022/08/02
Extracellular Vesicles  Exosomes  Cancer Immunotherapy  Immune Reprogramming  Immunogenic Cell Death